Dual Antiplatelet Therapy Versus Direct Oral Anticoagulation in High-Risk Patients Undergoing Left Atrial Appendage Occlusion With Watchman FLX.
BACKGROUND Optimal antithrombotic therapy after left atrial appendage occlusion remains uncertain. METHODS We studied 2817 patients undergoing left atrial appendage occlusion at 8 hospitals from 2016 to 2023 using registry data linked to Medicare claims. Among 2448 Watchman FLX recipients, the primary exposure was ti...